Detalhe da pesquisa
1.
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells.
Cytotherapy
; 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727653
2.
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Ann Hematol
; 98(9): 2151-2162, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31312927
3.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Biol Blood Marrow Transplant
; 23(1): 53-59, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27771496
4.
Impact of achievement of complete cytogenetic response on outcome in patients with myelodysplastic syndromes treated with hypomethylating agents.
Am J Hematol
; 92(4): 351-358, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076892
5.
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
Biol Blood Marrow Transplant
; 22(10): 1808-1815, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27470290
6.
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Bone Marrow Transplant
; 2024 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38755458
7.
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial.
Bone Marrow Transplant
; 59(3): 359-365, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38167647
8.
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Haematologica
; 98(4): 526-32, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23065527
9.
Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
Eur J Haematol
; 89(3): 250-5, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22642978
10.
Allogeneic Hematopoietic Stem Cell Transplantation in Transformed Follicular Lymphoma (tFL): Results of a Retrospective Multicenter Study from GELTAMO/GETH-TC Spanish Groups.
Cancers (Basel)
; 14(22)2022 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428762
11.
Downregulation of Protection of Telomeres 1 expression in myelodysplastic syndromes with 7q deletion.
Br J Haematol
; 173(1): 161-5, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26105212
12.
Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study.
Bone Marrow Transplant
; 56(8): 1919-1928, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767400
13.
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain.
Clin Lymphoma Myeloma Leuk
; 21(10): e801-e809, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376375
14.
Measures to Maintain a SARS-CoV-2 Negative Inpatient Hematological Unit in the Midst of the COVID-19 Pandemic.
Front Med (Lausanne)
; 7: 462, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984363
15.
PDE4 Differential Expression Is a Potential Prognostic Factor and Therapeutic Target in Patients With Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 16 Suppl: S67-73, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27521329
16.
Down-regulation of EZH2 expression in myelodysplastic syndromes.
Leuk Res
; 44: 1-7, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26970171
17.
Risk factors and outcomes of follicular lymphoma after allogeneic hematopoietic stem cell transplantation using HLA-matched sibling, unrelated, and haploidentical-related donors.
Bone Marrow Transplant
; 56(4): 992-996, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33311593
18.
Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: retrospective analysis of survival after long-term follow-up.
Leuk Res
; 39(5): 520-4, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25828745
19.
Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma.
Clin Case Rep
; 3(6): 370-5, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185631
20.
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes.
Leuk Res
; 39(12): 1367-74, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26547258